Table 3. Clinical and urodynamic data.
| Success | Pre treatment | Pre treatment | p | Post treatment | Post treatment | p |
|---|---|---|---|---|---|---|
| Asymptomatic bacteriuria (n = 138) | No bacteriuria (n = 54) | Asymptomatic bacteriuria (n = 138) | No bacteriuria (n = 54) | |||
| Urinary frequency/24 h | 7 ± 4 | 7 ± 3 | 0.84 | 5 ± 1 | 5 ± 2 | 0.22 |
| Incontinence episodes/24 h | 2 (0–3) | 2 (0–3) | 0.81 | 0 (0–0) | 0 (0–0) | 0.99 |
| MCC [mL] | 385 (250–555) | 410 (260–595) | 0.67 | 505 (360–715) | 535 (510–685) | 0.92 |
| Compliance [mL/cmH2O] | 45 (25–76) | 50 (29–74) | 0.58 | 55 (35–110) | 71 (39–107) | 0.35 |
| pdetmax storage [cmH2O] | 35 (22–54) | 40 (20–48) | 0.64 | 19 (11–33) | 15 (8–25) | 0.05 |
| First DO [mL] | 210 (110–325) | 230 (120–350) | 0.28 | 325 (190–445) | 350 (225–490) | 0.28 |
| DO | (138/138) | (54/54) | 0.99 | (98/138) | (32/54) | 0.68 |
| Failure | Asymptomatic bacteriuria (n = 62) | No Bacteriuria (n = 19) | Asymptomatic bacteriuria (n = 62) | No Bacteriuria (n = 19) | ||
| Urinary frequency/24 h | 7 ± 3 | 7 ± 3 | 0.57 | 6 ± 2 | 6 ± 2 | 0.67 |
| Incontinence episodes/24 h | 1 (1–3) | 2 (1–4) | 0.27 | 1 (0–1) | 1 (0–2) | 0.3 |
| MCC [mL] | 330 (195–515) | 410 (225–530) | 0.24 | 340 (90–525) | 345 (200–450) | 0.96 |
| Compliance [mL/cmH2O] | 32 (19–73) | 40 (27–100) | 0.15 | 33 (20–60) | 49 (32–100) | 0.06 |
| pdetmax storage [cmH2O] | 34 (23–65) | 22 (14–48) | 0.06 | 38 (18–58) | 34 (21–52) | 0.86 |
| First DO [mL] | 140 (90–310) | 205 (140–370) | 0.15 | 140 (85–270) | 190 (105–300) | 0.39 |
| DO | (62/62) | (19/19) | 0.99 | (57/62) | (18/19) | 0.12 |
MCC = maximum cystometric capacity; pdetmax storage = maximum detrusor pressure during storage phase; DO = detrusor overactivity; treatment = intradetrusor onabotulinumtoxinA injections.